[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]
IF | AIF | CIF | IF5 | DOC | CDO | CIT | NCI | CCU | D2Y | C2Y | D5Y | C5Y | SC | %SC | CiY | II | AII | |
1990 | 0 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | |||||
1991 | 0 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | |||||
1992 | 0 | 0.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | |||||
1993 | 0 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | |||||
1994 | 0 | 0.11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | |||||
1995 | 0 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | |||||
1996 | 0 | 0.22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | |||||
1997 | 0 | 0.23 | 0 | 0 | 10 | 10 | 6 | 0 | 0 | 0 | 0 | 0 | 0.1 | |||||
1998 | 0 | 0.27 | 0 | 0 | 12 | 22 | 2 | 0 | 10 | 10 | 0 | 0 | 0.12 | |||||
1999 | 0 | 0.29 | 0.18 | 0 | 0 | 22 | 0 | 4 | 22 | 22 | 0 | 0 | 0.14 | |||||
2000 | 0 | 0.34 | 0.03 | 0.05 | 9 | 31 | 0 | 1 | 5 | 12 | 22 | 1 | 0 | 0 | 0.15 | |||
2001 | 0 | 0.36 | 0 | 0 | 3 | 34 | 0 | 5 | 9 | 31 | 0 | 0 | 0.16 | |||||
2002 | 0 | 0.4 | 0.03 | 0.03 | 0 | 34 | 0 | 1 | 6 | 12 | 34 | 1 | 0 | 0 | 0.21 | |||
2003 | 0 | 0.41 | 0.03 | 0 | 5 | 39 | 1 | 1 | 7 | 3 | 24 | 0 | 0 | 0.2 | ||||
2004 | 0 | 0.46 | 0.03 | 0 | 1 | 40 | 1 | 1 | 8 | 5 | 17 | 0 | 0 | 0.21 | ||||
2005 | 0 | 0.47 | 0.02 | 0 | 7 | 47 | 1 | 1 | 9 | 6 | 18 | 0 | 0 | 0.22 | ||||
2006 | 0 | 0.47 | 0.02 | 0.06 | 62 | 109 | 42 | 2 | 11 | 8 | 16 | 1 | 1 | 50 | 0 | 0.21 | ||
2007 | 0.03 | 0.42 | 0.02 | 0.03 | 38 | 147 | 15 | 3 | 14 | 69 | 2 | 75 | 2 | 0 | 0 | 0.19 | ||
2008 | 0.01 | 0.45 | 0.01 | 0.01 | 22 | 169 | 75 | 1 | 15 | 100 | 1 | 113 | 1 | 1 | 100 | 0 | 0.21 | |
2009 | 0 | 0.44 | 0.02 | 0.01 | 28 | 197 | 12 | 3 | 18 | 60 | 130 | 1 | 0 | 0 | 0.21 | |||
2010 | 0.1 | 0.44 | 0.04 | 0.06 | 33 | 230 | 22 | 10 | 28 | 50 | 5 | 157 | 9 | 0 | 0 | 0.18 | ||
2011 | 0.05 | 0.46 | 0.04 | 0.04 | 32 | 262 | 51 | 10 | 38 | 61 | 3 | 183 | 7 | 3 | 30 | 2 | 0.06 | 0.21 |
2012 | 0.08 | 0.47 | 0.07 | 0.08 | 87 | 349 | 78 | 26 | 64 | 65 | 5 | 153 | 13 | 5 | 19.2 | 5 | 0.06 | 0.19 |
2013 | 0.19 | 0.53 | 0.13 | 0.16 | 96 | 445 | 200 | 56 | 120 | 119 | 23 | 202 | 32 | 21 | 37.5 | 11 | 0.11 | 0.22 |
2014 | 0.17 | 0.55 | 0.17 | 0.14 | 123 | 568 | 194 | 97 | 217 | 183 | 32 | 276 | 40 | 32 | 33 | 34 | 0.28 | 0.21 |
2015 | 0.26 | 0.55 | 0.18 | 0.2 | 105 | 673 | 113 | 123 | 340 | 219 | 57 | 371 | 75 | 33 | 26.8 | 17 | 0.16 | 0.21 |
2016 | 0.24 | 0.56 | 0.2 | 0.24 | 145 | 818 | 89 | 163 | 503 | 228 | 55 | 443 | 106 | 38 | 23.3 | 14 | 0.1 | 0.2 |
2017 | 0.17 | 0.58 | 0.19 | 0.19 | 116 | 934 | 67 | 179 | 682 | 250 | 43 | 556 | 106 | 52 | 29.1 | 24 | 0.21 | 0.21 |
2018 | 0.18 | 0.7 | 0.18 | 0.21 | 127 | 1061 | 28 | 196 | 878 | 261 | 47 | 585 | 121 | 37 | 18.9 | 7 | 0.06 | 0.28 |
2019 | 0.16 | 0.88 | 0.17 | 0.16 | 104 | 1165 | 8 | 197 | 1075 | 243 | 38 | 616 | 100 | 36 | 18.3 | 21 | 0.2 | 0.33 |
IF: | Impact Factor: C2Y / D2Y |
AIF: | Average Impact Factor for series in RePEc in year y |
CIF: | Cumulative impact factor |
IF5: | Impact Factor: C5Y / D5Y |
DOC: | Number of documents published in year y |
CDO: | Cumulative number of documents published until year y |
CIT: | Number of citations to papers published in year y |
NCI: | Number of citations in year y |
CCU: | Cumulative number of citations to papers published until year y |
D2Y: | Number of articles published in y-1 plus y-2 |
C2Y: | Cites in y to articles published in y-1 plus y-2 |
D5Y: | Number of articles published in y-1 until y-5 |
C5Y: | Cites in y to articles published in y-1 until y-5 |
SC: | selft citations in y to articles published in y-1 plus y-2 |
%SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
CiY: | Cites in year y to documents published in year y |
II: | Immediacy Index: CiY / Documents. |
AII: | Average Immediacy Index for series in RePEc in year y |
# | Year | Title | Cited |
---|---|---|---|
1 | 2013 | Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367. Full description at Econpapers || Download paper | 126 |
2 | 2008 | Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677. Full description at Econpapers || Download paper | 61 |
3 | 2014 | Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Moro, Domenico ; Petrou, Stavros ; Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902. Full description at Econpapers || Download paper | 26 |
4 | 2014 | Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69. Full description at Econpapers || Download paper | 23 |
5 | Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33. Full description at Econpapers || Download paper | 23 | |
6 | 2012 | Golimumab for the Treatment of Psoriatic Arthritis. (2012). Sculpher, Mark ; EPSTEIN, DAVID ; Woolacott, Nerys ; Bojke, Laura ; Light, Kate ; Bruce, Ian ; Yang, Huiqin ; Craig, Dawn. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:4:p:257-270. Full description at Econpapers || Download paper | 22 |
7 | 2015 | Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Cawley, John ; Biener, Adam ; Wintfeld, Neil ; Meyerhoefer, Chad ; Hammer, Mette . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722. Full description at Econpapers || Download paper | 14 |
8 | 2014 | Monetary policy challenges: how central banks changed their modus operandi. (2014). Giorgio, Giorgio . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:25-43. Full description at Econpapers || Download paper | 14 |
9 | 2017 | Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4. Full description at Econpapers || Download paper | 13 |
10 | 2014 | Japanâs monetary policy in a challenging environment. (2014). Shirai, Sayuri. In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-24. Full description at Econpapers || Download paper | 12 |
11 | 2013 | Operationalizing Value-Based Pricing of Medicines. (2013). Towse, Adrian ; Devlin, Nancy ; Sussex, Jon . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:1-10. Full description at Econpapers || Download paper | 11 |
12 | 2014 | The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86. Full description at Econpapers || Download paper | 11 |
13 | 2014 | Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965. Full description at Econpapers || Download paper | 11 |
14 | 2014 | Capitalâs grabbing hand? A cross-industry analysis of the decline of the labor share in OECD countries. (2014). Bassanini, Andrea ; Manfredi, Thomas . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-30. Full description at Econpapers || Download paper | 11 |
15 | 2014 | Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Neasham, David ; Lanitis, Tereza ; Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365. Full description at Econpapers || Download paper | 11 |
16 | 2014 | Effects of additional monetary tightening on exchange rates. (2014). Oduncu, Arif ; Akcelik, Yasin ; Taskin, Temel ; Ermisoglu, Ergun . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:71-79. Full description at Econpapers || Download paper | 11 |
17 | 2014 | Preferences for Oral Anticoagulants in Atrial Fibrillation: a BestâBest Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127. Full description at Econpapers || Download paper | 9 |
18 | 2006 | Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996â2003. (2006). Liu, Chien-Hsiang ; Lee, Yue-Chune ; Huang, Yu-Tung ; Chen, Sun-Bing ; Yang, Ming-Chin . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:891-902. Full description at Econpapers || Download paper | 9 |
19 | 2015 | Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. (2015). Viney, Rosalie ; Sermet, Catherine ; Parkinson, Bonny ; Elshaug, Adam ; Lopert, Ruth ; Pearson, Sallie-Anne ; Choudhury, Moni ; Garner, Sarah ; Godman, Brian ; Crausaz, Steffan ; Clement, Fiona . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:905-924. Full description at Econpapers || Download paper | 9 |
20 | 2015 | Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. (2015). Svensson, Mikael ; Nilsson, Fredrik ; Arnberg, Karl . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1229-1236. Full description at Econpapers || Download paper | 9 |
21 | 2015 | The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Seuring, Till ; Suhrcke, Marc ; Archangelidi, Olga . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831. Full description at Econpapers || Download paper | 9 |
22 | 2013 | Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making. (2013). Boer, Anthonius ; Franken, Margreet ; Koopmanschap, Marc ; Nilsson, Fredrik ; Sandmann, Frank . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:9:p:781-797. Full description at Econpapers || Download paper | 8 |
23 | 2016 | Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment. (2016). Kanavos, Panos ; Angelis, Aris. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0370-z. Full description at Econpapers || Download paper | 8 |
24 | 2014 | How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344. Full description at Econpapers || Download paper | 8 |
25 | 2012 | Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001â7. (2012). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:197-211. Full description at Econpapers || Download paper | 8 |
26 | 2016 | EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Luo, Nan ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1. Full description at Econpapers || Download paper | 8 |
27 | 2015 | Value-Based Reimbursement Decisions for Orphan Drugs: A Scoping Review and Decision Framework. (2015). McCabe, Christopher ; Stafinski, Tania ; Paulden, Mike ; Menon, Devidas . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:3:p:255-269. Full description at Econpapers || Download paper | 8 |
28 | 2014 | A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170. Full description at Econpapers || Download paper | 8 |
29 | Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Kreif, Noemi ; Benedict, Agnes ; Muszbek, Noemi ; Ishak, K.. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675. Full description at Econpapers || Download paper | 7 | |
30 | 2015 | A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028. Full description at Econpapers || Download paper | 6 |
31 | 2015 | Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment. (2015). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana ; Wetering, Liesbet . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:12:p:1289-1300. Full description at Econpapers || Download paper | 6 |
32 | 2006 | The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003. (2006). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:3:p:5-25. Full description at Econpapers || Download paper | 6 |
33 | 2012 | Does the EQ-5D Reflect Lost Earnings?. (2012). van Exel, Job ; Tsuchiya, Aki ; Brouwer, Werner ; Kro, Marieke ; Brazier, John ; Tilling, Carl . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:1:p:47-61. Full description at Econpapers || Download paper | 6 |
34 | 2013 | How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119. Full description at Econpapers || Download paper | 6 |
35 | 2015 | A Review and Classification of Approaches for Dealing with Uncertainty in Multi-Criteria Decision Analysis for Healthcare Decisions. (2015). Ijzerman, Maarten ; Broekhuizen, Henk ; Groothuis-Oudshoorn, Catharina ; Til, Janine ; Hummel, J.. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:5:p:445-455. Full description at Econpapers || Download paper | 6 |
36 | 2018 | Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues. (2018). Danzon, Patricia. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0696-4. Full description at Econpapers || Download paper | 5 |
37 | 2016 | Biosimilars: How Can Payers Get Long-Term Savings?. (2016). Towse, Adrian ; Berdud, Mikel ; Mestre-Ferrandiz, Jorge. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:6:d:10.1007_s40273-015-0380-x. Full description at Econpapers || Download paper | 5 |
38 | 2014 | Self-employment against employment or unemployment: Markov transitions across the business cycle. (2014). Constant, Amelie ; Zimmermann, Klaus. In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:51-87. Full description at Econpapers || Download paper | 5 |
39 | 2014 | Eliciting Preferences to Inform Patient-Centred Policies: the Case of Psoriasis. (2014). Torbica, Aleksandra ; Fattore, Giovanni ; Ayala, Fabio . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:2:p:209-223. Full description at Econpapers || Download paper | 5 |
40 | 2017 | The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; Oliva-Moreno, Juan ; del Pozo-Rubio, Raul ; Pea-Longobardo, Luz Maria ; Trapero-Bertran, Marta . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y. Full description at Econpapers || Download paper | 5 |
41 | 2006 | Generic Health-Related Quality-of-Life Assessment in Children and Adolescents. (2006). Nickel, Jennifer ; Ravens-Sieberer, Ulrike ; Wetzel, Ralf ; Wille, Nora ; Bullinger, Monika ; Erhart, Michael . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:12:p:1199-1220. Full description at Econpapers || Download paper | 5 |
42 | 2008 | Generic Entry, Reformulations and Promotion of SSRIs in the US. (2008). Koss, Catherine ; Frank, Richard ; Donohue, Julie ; Huskamp, Haiden ; Berndt, Ernst . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:7:p:603-616. Full description at Econpapers || Download paper | 5 |
43 | 2017 | A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models. (2017). Brazier, John ; Chevrou-Severac, Helene ; Rowen, Donna ; Ara, Roberta. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0545-x. Full description at Econpapers || Download paper | 5 |
44 | 2014 | Can the Real Opportunity Cost Stand Up: Displaced Services, the Straw Man Outside the Room. (2014). Pekarsky, Brita ; Eckermann, Simon. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:319-325. Full description at Econpapers || Download paper | 5 |
45 | 2011 | Do Productivity Costs Matter?. (2011). Brouwer, Werner ; Papenburg, Joce ; Krol, Marieke ; Koopmanschap, Marc . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:601-619. Full description at Econpapers || Download paper | 5 |
46 | 2010 | International Comparison of Comparative Effectiveness Research in Five Jurisdictions. (2010). Levy, Adrian ; Johnston, Karissa ; Mitton, Craig ; Harrigan, Brian ; Briggs, Andrew. In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:10:p:813-830. Full description at Econpapers || Download paper | 5 |
47 | 2012 | Continuous Time Simulation and Discretized Models for Cost-Effectiveness Analysis. (2012). Soares, Marta ; Luisa Canto e Castro, . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:12:p:1101-1117. Full description at Econpapers || Download paper | 5 |
48 | 2014 | Solo self-employed versus employer entrepreneurs: determinants and macro-economic effects in OECD countries. (2014). Stel, Andre ; Wennekers, Sander ; Scholman, Gerard . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:107-136. Full description at Econpapers || Download paper | 5 |
49 | 2016 | Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9. Full description at Econpapers || Download paper | 5 |
50 | 2010 | An Analysis of NICEâs âRestrictedâ (or âOptimizedâ) Decisions. (2010). Devlin, Nancy ; ONeill, Phill . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:11:p:987-993. Full description at Econpapers || Download paper | 5 |
# | Year | Title | Cited |
---|---|---|---|
1 | 2013 | Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367. Full description at Econpapers || Download paper | 34 |
2 | 2008 | Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677. Full description at Econpapers || Download paper | 19 |
3 | 2014 | Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Moro, Domenico ; Petrou, Stavros ; Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902. Full description at Econpapers || Download paper | 14 |
4 | 2017 | Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4. Full description at Econpapers || Download paper | 13 |
5 | 2014 | Capitalâs grabbing hand? A cross-industry analysis of the decline of the labor share in OECD countries. (2014). Bassanini, Andrea ; Manfredi, Thomas . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-30. Full description at Econpapers || Download paper | 9 |
6 | 2015 | The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Seuring, Till ; Suhrcke, Marc ; Archangelidi, Olga . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831. Full description at Econpapers || Download paper | 8 |
7 | 2014 | Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965. Full description at Econpapers || Download paper | 6 |
8 | 2016 | EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Luo, Nan ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1. Full description at Econpapers || Download paper | 6 |
9 | 2014 | The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86. Full description at Econpapers || Download paper | 6 |
10 | 2016 | Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment. (2016). Kanavos, Panos ; Angelis, Aris. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0370-z. Full description at Econpapers || Download paper | 6 |
11 | 2011 | Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33. Full description at Econpapers || Download paper | 5 |
12 | 2015 | Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment. (2015). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana ; Wetering, Liesbet . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:12:p:1289-1300. Full description at Econpapers || Download paper | 5 |
13 | 2015 | Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. (2015). Viney, Rosalie ; Sermet, Catherine ; Parkinson, Bonny ; Elshaug, Adam ; Lopert, Ruth ; Pearson, Sallie-Anne ; Choudhury, Moni ; Garner, Sarah ; Godman, Brian ; Crausaz, Steffan ; Clement, Fiona . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:905-924. Full description at Econpapers || Download paper | 5 |
14 | 2013 | Operationalizing Value-Based Pricing of Medicines. (2013). Towse, Adrian ; Devlin, Nancy ; Sussex, Jon . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:1-10. Full description at Econpapers || Download paper | 5 |
15 | 2018 | Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues. (2018). Danzon, Patricia. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0696-4. Full description at Econpapers || Download paper | 5 |
16 | 2015 | Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Cawley, John ; Biener, Adam ; Wintfeld, Neil ; Meyerhoefer, Chad ; Hammer, Mette . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722. Full description at Econpapers || Download paper | 5 |
17 | 2014 | How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344. Full description at Econpapers || Download paper | 5 |
18 | 2015 | A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028. Full description at Econpapers || Download paper | 4 |
19 | 2017 | The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications. (2017). Loblova, Olga ; Ferrario, Alessandra ; Kanavos, Panos ; Laidmae, Erki ; Haycox, Alan ; Jakupi, Arianit ; Voncina, Luka ; Hoxha, Iris ; Tomek, Dominik ; Greiit-Kuprijanov, Ieva ; Pomorski, Maciej ; Furst, Jurij ; Petrova, Guenka ; Dimitrova, Maria ; Novakovic, Tanja ; Danko, David ; Meshkov, Dmitry ; Ati, Tarik ; Markovic-Pekovic, Vanda ; Bochenek, Tomasz ; Godman, Brian ; Mardare, Ileana ; Arja, Dina ; Bonanno, Patricia Vella. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:12:d:10.1007_s40273-017-0559-4. Full description atManaging short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69. Full description at Econpapers || Download paper | 4 |
21 | 2014 | Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Neasham, David ; Lanitis, Tereza ; Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365. Full description at Econpapers || Download paper | 4 |
22 | 2018 | Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Janssen, Mathieu F ; Luo, Nan ; Bonsel, Gouke J. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8. Full description at Econpapers || Download paper | 4 |
23 | 2015 | Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. (2015). van Exel, Job ; Krol, Marieke ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:123-135. Full description at Econpapers || Download paper | 4 |
24 | 2013 | Reference Pricing and Price Negotiations for Innovative New Drugs. (2013). Gandjour, Afschin. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:11-14. Full description at Econpapers || Download paper | 4 |
25 | 2016 | Complex Valuation: Applying Ideas from the Complex Intervention Framework to Valuation of a New Measure for End-of-Life Care. (2016). Huynh, Elisabeth ; Kinghorn, Philip ; Flynn, Terry ; Coast, Joanna. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0365-9. Full description at Econpapers || Download paper | 4 |
26 | 2015 | Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. (2015). Svensson, Mikael ; Nilsson, Fredrik ; Arnberg, Karl . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1229-1236. Full description at Econpapers || Download paper | 4 |
27 | 2018 | Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Edney, Laura Catherine ; Karnon, Jonathan ; Cheng, Terence Chai ; Ali, Hossein Haji. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2. Full description at Econpapers || Download paper | 4 |
28 | 2019 | Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Soekhai, Vikas ; Vass, Caroline M ; Ellis, Alan R ; Bekker-Grob, Esther W. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2. Full description at Econpapers || Download paper | 4 |
29 | 2013 | Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making. (2013). Boer, Anthonius ; Franken, Margreet ; Koopmanschap, Marc ; Nilsson, Fredrik ; Sandmann, Frank . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:9:p:781-797. Full description at Econpapers || Download paper | 4 |
30 | 2015 | Value-Based Reimbursement Decisions for Orphan Drugs: A Scoping Review and Decision Framework. (2015). McCabe, Christopher ; Stafinski, Tania ; Paulden, Mike ; Menon, Devidas . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:3:p:255-269. Full description at Econpapers || Download paper | 4 |
31 | 2016 | Economic Evaluations of Opioid Use Disorder Interventions. (2016). Murphy, Sean M ; Polsky, Daniel . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:9:d:10.1007_s40273-016-0400-5. Full description at Econpapers || Download paper | 3 |
32 | 2016 | Assessing the Value of New Treatments for Hepatitis C: Are International Decision Makers Getting this Right?. (2016). Faria, Rita ; Griffin, Susan ; Woods, Beth . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0369-5. Full description at Econpapers || Download paper | 3 |
33 | 2017 | The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; Oliva-Moreno, Juan ; del Pozo-Rubio, Raul ; Pea-Longobardo, Luz Maria ; Trapero-Bertran, Marta . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y. Full description at Econpapers || Download paper | 3 |
34 | 2017 | The Indonesian EQ-5D-5L Value Set. (2017). Purba, Fredrick Dermawan ; An, J ; Passchier, Jan ; Ramos-Goi, Juan Manuel ; Sadarjoen, Sawitri Supardi ; Fitriana, Titi Sahidah ; Iskandarsyah, Aulia. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0538-9. Full description at Econpapers || Download paper | 3 |
35 | 2016 | Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9. Full description at Econpapers || Download paper | 3 |
36 | 2016 | Using BestâWorst Scaling to Investigate Preferences in Health Care. (2016). Hollin, Ilene L ; Cheung, Kei Long ; Hiligsmann, Mickael ; Silvia, ; Bridges, John F ; Janssen, Ellen M. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:12:d:10.1007_s40273-016-0429-5. Full description at Econpapers || Download paper | 3 |
37 | 2012 | Pricing Human Papillomavirus Vaccines. (2012). Curto, Alessandro ; Garattini, Livio ; Vooren, Katelijne . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:213-217. Full description at Econpapers || Download paper | 3 |
38 | 2011 | Sample Size and Power for Cost-Effectiveness Analysis (Part 2). (2011). Glick, Henry . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:4:p:287-296. Full description at Econpapers || Download paper | 3 |
39 | 2011 | Sample Size and Power for Cost-Effectiveness Analysis (Part 1). (2011). Glick, Henry . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:3:p:189-198. Full description at Econpapers || Download paper | 3 |
40 | 2013 | Decision-Makersâ Preferences for Approving New Medicines in Wales: A Discrete-Choice Experiment with Assessment of External Validity. (2013). Hughes, Dyfrig ; Linley, Warren . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:4:p:345-355. Full description at Econpapers || Download paper | 3 |
41 | 2016 | Pharmaceutical Price Schemes in Europe: Time for a âContinentalâ One?. (2016). Curto, Alessandro ; Freemantle, Nick ; Garattini, Livio. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0377-5. Full description at Econpapers || Download paper | 3 |
42 | 2017 | Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics. (2017). Morrell, Liz ; Barker, Richard ; Rees, Sian ; Wordsworth, Sarah . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:8:d:10.1007_s40273-017-0511-7. Full description at Econpapers || Download paper | 3 |
43 | 2014 | Preferences for Oral Anticoagulants in Atrial Fibrillation: a BestâBest Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127. Full description at Econpapers || Download paper | 3 |
44 | 2017 | Measuring Care-Related Quality of Life of Caregivers for Use in Economic Evaluations: CarerQol Tariffs for Australia, Germany, Sweden, UK, and US. (2017). van Exel, Job ; Hoefman, Renske J. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:4:d:10.1007_s40273-016-0477-x. Full description at Econpapers || Download paper | 3 |
45 | 2016 | Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial. (2016). Jamison, Dean T ; Kim, Jane J ; Verguet, Stephane. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:9:d:10.1007_s40273-016-0414-z. Full description at Econpapers || Download paper | 3 |
46 | 2018 | Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets. (2018). Shah, Koonal ; Feng, Yan ; Devlin, Nancy ; Hout, Ben ; Herdman, Michael ; Janssen, Mathieu F ; Mulhern, Brendan. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0628-3. Full description at Econpapers || Download paper | 3 |
47 | 2015 | Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review. (2015). Laurence, Yoko ; Vassall, Anna ; Griffiths, Ulla . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:939-955. Full description at Econpapers || Download paper | 3 |
48 | 2014 | Innovation for economic performance: the case of Latin American firms. (2014). Arias-Ortiz, Elena ; Zuiga, Pluvia ; Crespi, Gustavo ; Vargas, Fernando ; Tacsir, Ezequiel. In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:31-50. Full description at Econpapers || Download paper | 2 |
49 | 2014 | The Economic Burden of Head and Neck Cancer: A Systematic Literature Review. (2014). Pashos, Chris ; Foster, Talia ; Lungershausen, Juliane ; Griebsch, Ingolf ; Wissinger, Erika . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:865-882. Full description at Econpapers || Download paper | 2 |
50 | 2016 | Biosimilars: How Can Payers Get Long-Term Savings?. (2016). Towse, Adrian ; Berdud, Mikel ; Mestre-Ferrandiz, Jorge. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:6:d:10.1007_s40273-015-0380-x. Full description at Econpapers || Download paper | 2 |
Year | Title | |
---|---|---|
2019 | Catastrophic financial effect of replacing informal care with formal care: a study based on haematological neoplasms. (2019). Ortega-Ortega, Marta ; Pozo-Rubio, Raul. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:2:d:10.1007_s10198-018-0998-7. Full description at Econpapers || Download paper | |
2019 | How relevant are social costs in economic evaluations? The case of Alzheimerâs disease. (2019). Oliva-Moreno, J ; Rodriguez-Sanchez, B ; Pea-Longobardo, L M ; Lopez-Bastida, J ; Aranda-Reneo, I. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:8:d:10.1007_s10198-019-01087-6. Full description at Econpapers || Download paper | |
2019 | International HTA Experience with Targeted Therapy Approvals for Lung Cancer. (2019). Hinder, M ; Tuffaha, H ; Byrnes, J ; Maraiki, Fatma. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:1:d:10.1007_s41669-018-0088-x. Full description at Econpapers || Download paper | |
2019 | Stratified medicine in schizophrenia: how accurate would a test of drug response need to be to achieve cost-effective improvements in quality of life?. (2019). MacCabe, James H ; McCrone, Paul ; Jin, Huajie . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:9:d:10.1007_s10198-019-01108-4. Full description at Econpapers || Download paper | |
2019 | Public Preferences for Health Gains and Cures: A Discrete Choice Experiment. (2019). Shah, Koonal ; Mott, David ; Hampson, Grace ; Devlin, Nancy. In: Consulting Reports. RePEc:ohe:conrep:002108. Full description at Econpapers || Download paper | |
2019 | Sugar-sweetened beverage price elasticities in a hypothetical convenience store. (2019). Backholer, Kathryn ; Peeters, Anna ; Lancsar, Emily ; Blake, Miranda R. In: Social Science & Medicine. RePEc:eee:socmed:v:225:y:2019:i:c:p:98-107. Full description at Econpapers || Download paper | |
2019 | Mission of the company, prosocial attitudes and job preferences: a discrete choice experiment. (2019). Non, Arjan ; Dohmen, Thomas ; de Grip, Andries ; Rohde, Ingrid . In: Research Memorandum. RePEc:unm:umagsb:2019020. Full description at Econpapers || Download paper | |
2019 | Mission of the company, prosocial attitudes and job preferences: A discrete choice experiment. (2019). Non, Arjan ; Dohmen, Thomas ; de Grip, Andries ; Rohde, Ingrid . In: ROA Research Memorandum. RePEc:unm:umaror:2019006. Full description at Econpapers || Download paper | |
2019 | Farmers preferences for high-input agriculture supported by site-specific extension services: Evidence from a choice experiment in Nigeria. (2019). Maertens, Miet ; Craufurd, Peter ; Kamara, Yaya Alpha ; Vranken, Liesbet ; Vanlauwe, Bernard ; Chamberlin, Jordan ; Oyinbo, Oyakhilomen. In: Agricultural Systems. RePEc:eee:agisys:v:173:y:2019:i:c:p:12-26. Full description at Econpapers || Download paper | |
2019 | The role of heterogeneity of patientsâ preferences in kidney transplantation. (2019). Pasini, Giacomo ; Genie, Mesfin G ; Nicolo, Antonio. In: Working Papers. RePEc:ven:wpaper:2019:25. Full description at Econpapers || Download paper | |
2019 | Assessing quality of care in nursing homes using discrete choice experiments: How does the level of cognitive functioning impact upon older peoples preferences?. (2019). Ratcliffe, Julie ; Huynh, Elisabeth ; Milte, Rachel. In: Social Science & Medicine. RePEc:eee:socmed:v:238:y:2019:i:c:8. Full description at Econpapers || Download paper | |
2019 | Farmersââ¬â¢ willingness to accept payments for ecosystem services on agricultural land: The case of climate-smart agroforestry in Ethiopia. (2019). Tesfaye, Wondimagegn ; Tirivayi, Nyasha ; Haile, Kaleab K. In: Ecosystem Services. RePEc:eee:ecoser:v:39:y:2019:i:c:s2212041619300130. Full description at Econpapers || Download paper | |
2019 | Cost-effectiveness of precision medicine: a scoping review. (2019). Bempong, Nefti-Eboni ; Richard, Aude ; Kasztura, Miriam ; Flahault, Antoine ; Loncar, Dejan. In: International Journal of Public Health. RePEc:spr:ijphth:v:64:y:2019:i:9:d:10.1007_s00038-019-01298-x. Full description at Econpapers || Download paper | |
2019 | Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare. (2019). Hampson, Grace ; Wong, Olivier ; Schulenburg, J-Matthias Graf ; Towse, Adrian ; Michaels, Jonathan ; Jonsson, Bengt. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:3:d:10.1007_s10198-018-1007-x. Full description at Econpapers || Download paper | |
2019 | âWhatâs fair to an individual is not always fair to a populationâ: A qualitative study of patients and their health professionals using the Cancer Drugs Fund. (2019). MacKichan, Fiona ; Owen-Smith, Amanda ; Chamberlain, Charlotte ; Hollingworth, William ; Donovan, Jenny L. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:8:p:706-712. Full description at Econpapers || Download paper | |
2019 | Patient-Community Perspectives on Real-World Evidence: Enhancing Engagement, Understanding, and Trust. (2019). Perfetto, Eleanor M ; Harris, Jason ; Graff, Jennifer S ; Oehrlein, Elisabeth M. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:12:y:2019:i:4:d:10.1007_s40271-019-00356-z. Full description at Econpapers || Download paper | |
2019 | Valuation of preference-based measures: can existing preference data be used to select a smaller sample of health states?. (2019). Kharroubi, Samer A ; Rowen, Donna. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:2:d:10.1007_s10198-018-0991-1. Full description at Econpapers || Download paper | |
2019 | Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Soekhai, Vikas ; Vass, Caroline M ; Ellis, Alan R ; Bekker-Grob, Esther W. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2. Full description at Econpapers || Download paper | |
2019 | Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis. (2019). , Carlos ; Carlos , ; Yang, Fan ; Jackson, James ; Moon, Rebecca ; Piercy, James ; Luo, Nan. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:8:d:10.1007_s10198-019-01088-5. Full description at Econpapers || Download paper | |
2019 | One Method, Many Methodological Choices: A Structured Review of Discrete-Choice Experiments for Health State Valuation. (2019). Mulhern, Brendan ; Viney, Rosalie ; Street, Deborah J ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:1:d:10.1007_s40273-018-0714-6. Full description at Econpapers || Download paper | |
2019 | Measuring Health Spillover Effects in Caregivers of Children with Autism Spectrum Disorder: A Comparison of the EQ-5D-3L and SF-6D. (2019). Brouwer, Werner ; Hoefman, Renske J ; Pyne, Jeffrey M ; Kuhlthau, Karen A ; Williams, Keith D ; Payakachat, Nalin ; Tilford, Mick J ; Brown, Clare C. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00789-2. Full description at Econpapers || Download paper | |
2019 | Spillover Effects on Caregiversâ and Family Membersâ Utility: A Systematic Review of the Literature. (2019). Wittenberg, Eve ; Prosser, Lisa A ; James, Lyndon P. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00768-7. Full description at Econpapers || Download paper | |
2019 | When is it too expensive? Cost-effectiveness thresholds and health care decision-making. (2019). Brouwer, Werner ; Versteegh, Matthijs ; Exel, Job ; Baal, Pieter. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:2:d:10.1007_s10198-018-1000-4. Full description at Econpapers || Download paper | |
2019 | Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers. (2019). Walker, Simon ; Sculpher, Mark ; Tsuchiya, Aki ; Asaria, Miqdad ; Griffin, Susan. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:17:y:2019:i:5:d:10.1007_s40258-019-00481-8. Full description at Econpapers || Download paper | |
2019 | Estimating the marginal cost of a life year in Swedenâs public healthcare sector. (2019). Henriksson, Martin ; Siverskog, Jonathan. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:5:d:10.1007_s10198-019-01039-0. Full description at Econpapers || Download paper | |
2019 | The WHO Technical Report on the Pricing of Cancer Medicines: Missing a central role for HTA and value assessment. (2019). Brassel, Simon ; Towse, A ; Rozanova, O. In: Research Papers. RePEc:ohe:respap:002154. Full description at Econpapers || Download paper | |
2019 | Threats to the value of Health Technology Assessment: Qualitative evidence from Canada and Poland. (2019). Sevgur, Serperi ; Gambold, Liesl ; Zieliska, Dorota Anna ; Wranik, Wiesawa Dominika. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:2:p:191-202. Full description at Econpapers || Download paper | |
2019 | Denosumab versus bisphosphonates for the treatment of bone metastases from solid tumors: a systematic review. (2019). Secoli, Silvia R ; Kahn, James G ; Matuoka, Jessica Y. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:4:d:10.1007_s10198-018-1011-1. Full description at Econpapers || Download paper | |
2019 | A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private Payers. (2019). Xie, Feng ; Tarride, Jean-Eric ; Foroutan, Naghmeh ; Levine, Mitchell ; Mills, Fergal. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:4:d:10.1007_s41669-019-0139-y. Full description at Econpapers || Download paper | |
2019 | The Impact of Moving from EQ-5D-3L to -5L in NICE Technology Appraisals. (2019). pudney, stephen ; Wailoo, Allan ; Hernandez-Alava, Monica ; Pennington, Becky. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:1:d:10.1007_s40273-018-0701-y. Full description at Econpapers || Download paper | |
2019 | A new method for valuing health: directly eliciting personal utility functions. (2019). Shah, Koonal ; Devlin, Nancy ; van Hout, Ben ; Pantiri, Krystallia ; Mulhern, Brendan J. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:2:d:10.1007_s10198-018-0993-z. Full description at Econpapers || Download paper | |
2019 | A head-to-head comparison of five-level (EQ-5D-5L-Y) and three-level EQ-5D-Y questionnaires in paediatric patients. (2019). Yin, Jason Pui ; Luo, Nan ; Hang, Prudence Wing ; Ho, Carlos King. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:5:d:10.1007_s10198-018-1026-7. Full description at Econpapers || Download paper | |
2019 | Economic analysis for health benefits package design. (2019). Arnold, Matthias ; Sculpher, Mark ; Ochalek, Jessica ; Walker, Simon ; Sibandze, Sibusiso ; Revill, Paul ; Kataika, Edward ; Griffin, Susan ; Love-Koh, James. In: Working Papers. RePEc:chy:respap:165cherp. Full description at Econpapers || Download paper | |
2019 | Easy cuts, easy rebound: Drug expenditures with massive price cuts in Korea. (2019). Park, Sylvia ; Choi, Sang-Eun ; Bae, Seungjin ; Kwon, Hye-Young ; Kim, Jin Hyun ; Lee, Eui-Kyung . In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:4:p:388-392. Full description at Econpapers || Download paper | |
2019 | Alternative access schemes for pharmaceuticals in Europe: Towards an emerging typology. (2019). Csanadi, Marcell ; Loblova, Olga ; McKee, Martin ; King, Lawrence ; Kalo, Zoltan ; Ozieraski, Piotr. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:7:p:630-634. Full description at Econpapers || Download paper | |
2019 | Patterns of alternative access: Unpacking the Slovak extraordinary drug reimbursement regime 2012-2016. (2019). Ozieraski, Piotr ; Csanadi, Marcell ; Loblova, Olga ; McKee, Martin ; King, Lawrence ; Kalo, Zoltan. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:8:p:713-720. Full description at Econpapers || Download paper | |
2019 | Accounts from developers of generic health state utility instruments explain why they produce different QALYs: A qualitative study. (2019). Carter, Stacy M ; Donaldson, Cam ; Parkin, David ; Seymour, Janelle ; Lancsar, Emily ; Pickles, Kristen. In: Social Science & Medicine. RePEc:eee:socmed:v:240:y:2019:i:c:s0277953619305544. Full description at Econpapers || Download paper | |
2019 | Parallel imports, price controls, and innovation. (2019). Zenger, Hans ; Sauri, Lluis ; Reisinger, Markus. In: Journal of Health Economics. RePEc:eee:jhecon:v:66:y:2019:i:c:p:163-179. Full description at Econpapers || Download paper |
Year | Citing document | |
---|---|---|
2019 | Discrete Choice under Oaths. (2019). Watson, Verity ; Shogren, Jason ; Jacquemet, Nicolas ; Luchini, Stephane. In: Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers). RePEc:hal:cesptp:halshs-02136103. Full description at Econpapers || Download paper | |
2019 | Discrete Choice under Oaths. (2019). Watson, Verity ; Shogren, Jason ; Jacquemet, Nicolas ; Luchini, Stephane. In: Documents de travail du Centre d'Economie de la Sorbonne. RePEc:mse:cesdoc:19007. Full description at Econpapers || Download paper | |
2019 | Public Preferences for Health Gains and Cures: A Discrete Choice Experiment. (2019). Shah, Koonal ; Mott, David ; Hampson, Grace ; Devlin, Nancy. In: Consulting Reports. RePEc:ohe:conrep:002108. Full description at Econpapers || Download paper | |
2019 | Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States. (2019). Basu, Anirban ; Walton, Surrey M ; Carlson, Josh J ; Ollendorf, Daniel A ; Whittington, Melanie D ; Veenstra, David ; Touchette, Daniel R ; Pearson, Steven D ; McQueen, Brett R ; Campbell, Jonathan D ; Chapman, Richard H. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:11:d:10.1007_s40273-019-00832-2. Full description at Econpapers || Download Improving Transparency in Decision Models: Current Issues and Potential Solutions. (2019). Caro, Jaime J ; Tappenden, Paul. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:11:d:10.1007_s40273-019-00850-0. Full description at Econpapers || Download paper | |
2019 | Spillover Effects on Caregiversâ and Family Membersâ Utility: A Systematic Review of the Literature. (2019). Wittenberg, Eve ; Prosser, Lisa A ; James, Lyndon P. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00768-7. Full description at Econpapers || Download paper | |
2019 | Advances in Methods and Novel Applications for Measuring Family Spillover Effects of Illness. (2019). Prosser, Lisa A ; Wittenberg, Eve . In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00794-5. Full description at Econpapers || Download paper |
Year | Citing document | |
---|---|---|
2018 | Estimating the marginal productivity of the English National Health Service from 2003/04 to 2012/13. (2018). Claxton, Karl ; Martin, Stephen ; Lomas, James. In: Working Papers. RePEc:chy:respap:158cherp. Full description at Econpapers || Download paper | |
2018 | Intended and unintended impacts of price changes for drugs and medical services: Evidence from China. (2018). Fu, Hongqiao ; Yip, Winnie ; Li, Ling. In: Social Science & Medicine. RePEc:eee:socmed:v:211:y:2018:i:c:p:114-122. Full description at Econpapers || Download paper | |
2018 | Model Structuring for Economic Evaluations of New Health Technologies. (2018). Ali, Hossein Haji ; Karnon, Jonathan ; Bojke, Laura. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:11:d:10.1007_s40273-018-0693-7. Full description at Econpapers || Download paper | |
2018 | Multi-Indication Pricing: Nice in Theory but Can it Work in Practice?. (2018). Mestre-Ferrandiz, Jorge ; Hidalgo-Vega, alvaro ; Alcala, Bleric ; Zozaya, Neboa . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0716-4. Full description at Econpapers || Download paper | |
2018 | 3L, 5L, What the L? A NICE Conundrum. (2018). Devlin, Nancy ; Stolk, Elly ; Pickard, Simon A ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0622-9. Full description at Econpapers || Download paper | |
2018 | Head-to-Head Comparison of EQâ5Dâ3L and EQâ5Dâ5L Health Values. (2018). Selivanova, Anna ; Buskens, Erik . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0647-0. Full description at Econpapers || Download paper |
Year | Citing document | |
---|---|---|
2017 | Valuing Informal Care in Ireland: Beyond the Traditional Production Boundary. (2017). Hanly, Paul ; Sheerin, Corina. In: The Economic and Social Review. RePEc:eso:journl:v:48:y:2017:i:3:p:337-364. Full description at Econpapers || Download paper | |
2017 | Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Opportunities and Challenges. (2017). Lamsal, Ramesh ; Zwicker, Jennifer D. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:6:d:10.1007_s40258-017-0343-9. Full description at Econpapers || Download paper | |
2017 | The Ball is in Your Court: Agenda for Research to Advance the Science of Patient Preferences in the Regulatory Review of Medical Devices in the United States. (2017). Levitan, Bennett ; Christopher, Stephanie ; Jaffe, Ross ; Damiano, Marina G ; Hauber, Brett A. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:10:y:2017:i:5:d:10.1007_s40271-017-0272-6. Full description at Econpapers || Download paper | |
2017 | Discrete Event Simulation-Based Resource Modelling in Health Technology Assessment. (2017). Salleh, Syed ; Dixon, Simon ; Hughes, Ruby ; Brennan, Alan ; Thokala, Praveen. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:10:d:10.1007_s40273-017-0533-1. Full description at Econpapers || Download paper | |
2017 | Response to âComment on âReplicating Health Economic Models: Firm Foundations or a House of Cards?ââ. (2017). Bermejo, Inigo ; Youn, Ji-Hee ; Tappenden, Paul. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0574-5. Full description at Econpapers || Download paper | |
2017 | Comment on âReplicating Health Economic Models: Firm Foundations or a House of Cards?â. (2017). McManus, Emma ; Sach, Tracey. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0576-3. Full description at Econpapers || Download paper | |
2017 | The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications. (2017). Loblova, Olga ; Ferrario, Alessandra ; Kanavos, Panos ; Laidmae, Erki ; Haycox, Alan ; Jakupi, Arianit ; Voncina, Luka ; Hoxha, Iris ; Tomek, Dominik ; Greiit-Kuprijanov, Ieva ; Pomorski, Maciej ; Furst, Jurij ; Petrova, Guenka ; Dimitrova, Maria ; Novakovic, Tanja ; Danko, David ; Meshkov, Dmitry ; Ati, Tarik ; Markovic-Pekovic, Vanda ; Bochenek, Tomasz ; Godman, Brian ; Mardare, Ileana ; Arja, Dina ; Bonanno, Patricia Vella. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:12:d:10.1007_s40273-017-0559-4. Full description atHeath State Utility Values for Cost-Effectiveness Models. (2017). Karnon, Jonathan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0537-x. Full description at Econpapers || Download paper | |
2017 | The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment. (2017). Rowen, Donna ; Zouraq, Ismail Azzabi ; Ara, Roberta ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0546-9. Full description at Econpapers || Download paper | |
2017 | The Identification, Review and Synthesis of Health State Utility Values from the Literature. (2017). Ara, Roberta ; Paisley, Suzy ; Peasgood, Tessa ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0547-8. Full description at Econpapers || Download paper | |
2017 | The Use of Mapping to Estimate Health State Utility Values. (2017). Ara, Roberta ; Mukuria, Clara ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0548-7. Full description at Econpapers || Download paper | |
2017 | Recommended Methods for the Collection of Health State Utility Value Evidence in Clinical Studies. (2017). Ara, Roberta ; Young, Tracey ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0549-6. Full description at Econpapers || Download paper | |
2017 | The Use of Health State Utility Values in Decision Models. (2017). Ara, Roberta ; Zouraq, Ismail Azzabi ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0550-0. Full description at Econpapers || Download paper | |
2017 | Making Implicit Assumptions Explicit in the Costing of Informal Care: The Case of Head and Neck Cancer in Ireland. (2017). Hanly, Paul ; Sharp, Linda ; Osullivan, Eleanor ; Balfe, Myles ; Maguire, Rebecca. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:5:d:10.1007_s40273-017-0490-8. Full description at Econpapers || Download paper | |
2017 | Response to Letter to the Editor Regarding âAbiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of a NI. (2017). , Bram ; Joore, Manuela A ; Kleijnen, Jos ; Severens, Johan L ; Armstrong, Nigel ; Duffy, Steven ; Deshpande, Sohan ; Asselt, Thea ; Tomini, Florian ; Riemsma, Rob. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:6:d:10.1007_s40273-017-0507-3. Full description at Econpapers || Download An Investigation of the Overlap Between the ICECAP-A and Five Preference-Based Health-Related Quality of Life Instruments. (2017). Engel, Lidia ; David, ; Lear, Scott A ; Bryan, Stirling ; Mortimer, Duncan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0491-7. Full description at Econpapers || Download paper | |
2017 | Ahead of Our Time: Collaboration in Modeling Then and Now. (2017). , Renee ; Ekins, Sean . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:9:d:10.1007_s40273-017-0532-2. Full description at Econpapers || Download paper |
Year | Citing document | |
---|---|---|
2016 | Fairer decisions, better health for all: Health equity and cost-effectiveness analysis. (2016). Asaria, Miqdad ; Mirelman, Andrew ; Cookson, Richard ; Griffin, Susan ; Dawkins, Bryony . In: Working Papers. RePEc:chy:respap:135cherp. Full description at Econpapers || Download paper | |
2016 | Expanding professional pharmacy services in European community setting: Is it cost-effective? A systematic review for health policy considerations. (2016). Bugnon, Olivier ; Perraudin, Clemence ; Pelletier-Fleury, Nathalie . In: Health Policy. RePEc:eee:hepoli:v:120:y:2016:i:12:p:1350-1362. Full description at Econpapers || Download paper | |
2016 | Limiting Free Pricing of New Innovative Drugs After Launch: A Necessity for Payers?. (2016). Gandjour, Afschin. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:14:y:2016:i:5:d:10.1007_s40258-016-0247-0. Full description at Econpapers || Download paper | |
2016 | Reimbursable drug classes and ceilings in Italy: why not only one?. (2016). Padula, Anna ; Curto, Alessandro ; Garattini, Livio. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:17:y:2016:i:8:d:10.1007_s10198-016-0808-z. Full description at Econpapers || Download paper | |
2016 | Daclatasvir for the Treatment of Chronic Hepatitis C: A Critique of the Clinical and Economic Evidence. (2016). Faria, Rita ; Llewellyn, Alexis ; Woods, Beth ; Griffin, Susan ; Woolacott, Nerys ; Lomas, James ; Simmonds, Mark . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0418-8. Full description at Econpapers || Download paper | |
2016 | Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience. (2016). Bocquet, Franois ; Paubel, Pascal ; Cordonnier, Anne-Laure ; Fusier, Isabelle ; Loubiere, Anais . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:11:d:10.1007_s40273-016-0428-6. Full description at Econpapers || Download paper | |
2016 | Big Data and Its Role in Health Economics and Outcomes Research: A Collection of Perspectives on Data Sources, Measurement, and Analysis. (2016). Onukwugha, Eberechukwu . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:2:d:10.1007_s40273-015-0378-4. Full description at Econpapers || Download paper | |
2016 | Big Data and Its Role in Health Economics and Outcomes Research: A Collection of Perspectives on Data Sources, Measurement, and Analysis. (2016). Onukwugha, Eberechukwu . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:2:p:91-93. Full description at Econpapers || Download paper | |
2016 | Why Cancer?. (2016). Haycox, Alan. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0413-0. Full description at Econpapers || Download paper | |
2016 | Model Validation: Has itâs Time Come?. (2016). Karnon, Jonathan. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:9:d:10.1007_s40273-016-0415-y. Full description at Econpapers || Download paper |